Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1991 Jul-Aug;64(4):387–402.

Acute respiratory distress syndrome--two decades later.

A J Cunningham 1
PMCID: PMC2589549  PMID: 1814055

Abstract

Twenty years have now elapsed since Ashbaugh and Petty first described the syndrome of acute respiratory failure associated with a wide spectrum of clinical conditions. During the past two decades, significant advances have emerged in our understanding of the clinical conditions associated with the syndrome and the pathophysiological changes affecting the alveolar-capillary membrane responsible for the characteristic non-cardiogenic pulmonary edema. Recent data have reaffirmed the notion that mortality rates in ARDS remain in excess of 60 percent, essentially unchanged since the first description of the syndrome, despite all the advances in critical care medicine in the intervening years. The incidence of ARDS has been difficult to establish because of lack of agreement on precise definition criteria. The lack of agreed definition criteria has hampered evaluation of the natural history of the syndrome, its epidemiology and mortality rates, and the efficacy or otherwise of a variety of therapeutic interventions. This review will highlight a recent, clinically appropriate, expanded definition of ARDS. New understandings of the roles of sepsis and multi-system organ failure in mortality associated with ARDS will be discussed. Several mediators, both locally in the lung and in the systemic circulation, have been implicated in the pathophysiology of ARDS. This review will discuss the evidence for and against neutrophils, platelets, cytokines derived from mononuclear cells and macrophages, complement, prostaglandins/leukotrienes, oxygen-derived radicals, and a variety of proteases. Current treatment strategies for ARDS are designed to increase tissue oxygen delivery by increasing arterial oxygen tension and cardiac output while simultaneously attenuating the pulmonary and systemic injury by appropriate pharmacologic and surgical interventions. Recent data advocating pharmacological augmentation of cardiac index and oxygen delivery will be highlighted. The persistently high mortality rates of 60-70 percent in patients with established ARDS have provoked recurring interest in new techniques of providing mechanical ventilation. Most studies have shown, however, that mortality in ARDS patients is attributable mainly to sepsis and multi-system organ failure rather than primarily to respiratory failure. Established and speculative intervention to reduce sepsis and multi-system organ failure associated with ARDS will be featured in the review.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berthiaume Y., Albertine K. H., Grady M., Fick G., Matthay M. A. Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. J Appl Physiol (1985) 1989 Nov;67(5):1887–1897. doi: 10.1152/jappl.1989.67.5.1887. [DOI] [PubMed] [Google Scholar]
  2. Beutler B. A., Milsark I. W., Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol. 1985 Dec;135(6):3972–3977. [PubMed] [Google Scholar]
  3. Carlon G. C., Howland W. S., Ray C., Miodownik S., Griffin J. P., Groeger J. S. High-frequency jet ventilation. A prospective randomized evaluation. Chest. 1983 Nov;84(5):551–559. doi: 10.1378/chest.84.5.551. [DOI] [PubMed] [Google Scholar]
  4. Dehring D. J., Wismar B. L. Intravascular macrophages in pulmonary capillaries of humans. Am Rev Respir Dis. 1989 Apr;139(4):1027–1029. doi: 10.1164/ajrccm/139.4.1027. [DOI] [PubMed] [Google Scholar]
  5. Dorinsky P. M., Gadek J. E. Mechanisms of multiple nonpulmonary organ failure in ARDS. Chest. 1989 Oct;96(4):885–892. doi: 10.1378/chest.96.4.885. [DOI] [PubMed] [Google Scholar]
  6. Duchateau J., Haas M., Schreyen H., Radoux L., Sprangers I., Noel F. X., Braun M., Lamy M. Complement activation in patients at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis. 1984 Dec;130(6):1058–1064. doi: 10.1164/arrd.1984.130.6.1058. [DOI] [PubMed] [Google Scholar]
  7. Fein A. M., Lippmann M., Holtzman H., Eliraz A., Goldberg S. K. The risk factors, incidence, and prognosis of ARDS following septicemia. Chest. 1983 Jan;83(1):40–42. doi: 10.1378/chest.83.1.40. [DOI] [PubMed] [Google Scholar]
  8. Fowler A. A., Hamman R. F., Zerbe G. O., Benson K. N., Hyers T. M. Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis. 1985 Sep;132(3):472–478. doi: 10.1164/arrd.1985.132.3.472. [DOI] [PubMed] [Google Scholar]
  9. Gattinoni L., Pesenti A., Mascheroni D., Marcolin R., Fumagalli R., Rossi F., Iapichino G., Romagnoli G., Uziel L., Agostoni A. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA. 1986 Aug 15;256(7):881–886. [PubMed] [Google Scholar]
  10. Ghio A. J., Elliott C. G., Crapo R. O., Berlin S. L., Jensen R. L. Impairment after adult respiratory distress syndrome. An evaluation based on American Thoracic Society recommendations. Am Rev Respir Dis. 1989 May;139(5):1158–1162. doi: 10.1164/ajrccm/139.5.1158. [DOI] [PubMed] [Google Scholar]
  11. Gilbert E. M., Haupt M. T., Mandanas R. Y., Huaringa A. J., Carlson R. W. The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis. Am Rev Respir Dis. 1986 Nov;134(5):873–878. doi: 10.1164/arrd.1986.134.5.873. [DOI] [PubMed] [Google Scholar]
  12. Hammerschmidt D. E., Weaver L. J., Hudson L. D., Craddock P. R., Jacob H. S. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. Lancet. 1980 May 3;1(8175):947–949. doi: 10.1016/s0140-6736(80)91403-8. [DOI] [PubMed] [Google Scholar]
  13. Heffner J. E., Sahn S. A., Repine J. E. The role of platelets in the adult respiratory distress syndrome. Culprits or bystanders? Am Rev Respir Dis. 1987 Feb;135(2):482–492. doi: 10.1164/arrd.1987.135.2.482. [DOI] [PubMed] [Google Scholar]
  14. Idell S., Gonzalez K., Bradford H., MacArthur C. K., Fein A. M., Maunder R. J., Garcia J. G., Griffith D. E., Weiland J., Martin T. R. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis. 1987 Dec;136(6):1466–1474. doi: 10.1164/ajrccm/136.6.1466. [DOI] [PubMed] [Google Scholar]
  15. Langer M., Mosconi P., Cigada M., Mandelli M. Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis. 1989 Aug;140(2):302–305. doi: 10.1164/ajrccm/140.2.302. [DOI] [PubMed] [Google Scholar]
  16. Luce J. M., Montgomery A. B., Marks J. D., Turner J., Metz C. A., Murray J. F. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988 Jul;138(1):62–68. doi: 10.1164/ajrccm/138.1.62. [DOI] [PubMed] [Google Scholar]
  17. MacIntyre N. R., Follett J. V., Deitz J. L., Lawlor B. R. Jet ventilation at 100 breaths per minute in adult respiratory failure. Am Rev Respir Dis. 1986 Nov;134(5):897–901. doi: 10.1164/arrd.1986.134.5.897. [DOI] [PubMed] [Google Scholar]
  18. Mancebo J., Artigas A. A clinical study of the adult respiratory distress syndrome. Crit Care Med. 1987 Mar;15(3):243–246. doi: 10.1097/00003246-198703000-00013. [DOI] [PubMed] [Google Scholar]
  19. Matthay M. A. New modes of mechanical ventilation for ARDS. How should they be evaluated? Chest. 1989 Jun;95(6):1175–1177. doi: 10.1378/chest.95.6.1175. [DOI] [PubMed] [Google Scholar]
  20. Matthay M. A. The adult respiratory distress syndrome. New insights into diagnosis, pathophysiology, and treatment. West J Med. 1989 Feb;150(2):187–194. [PMC free article] [PubMed] [Google Scholar]
  21. Montgomery A. B., Stager M. A., Carrico C. J., Hudson L. D. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985 Sep;132(3):485–489. doi: 10.1164/arrd.1985.132.3.485. [DOI] [PubMed] [Google Scholar]
  22. Murray J. F., Matthay M. A., Luce J. M., Flick M. R. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988 Sep;138(3):720–723. doi: 10.1164/ajrccm/138.3.720. [DOI] [PubMed] [Google Scholar]
  23. Ognibene F. P., Martin S. E., Parker M. M., Schlesinger T., Roach P., Burch C., Shelhamer J. H., Parrillo J. E. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med. 1986 Aug 28;315(9):547–551. doi: 10.1056/NEJM198608283150904. [DOI] [PubMed] [Google Scholar]
  24. Parker M. M., Shelhamer J. H., Bacharach S. L., Green M. V., Natanson C., Frederick T. M., Damske B. A., Parrillo J. E. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984 Apr;100(4):483–490. doi: 10.7326/0003-4819-100-4-483. [DOI] [PubMed] [Google Scholar]
  25. Pepe P. E., Hudson L. D., Carrico C. J. Early application of positive end-expiratory pressure in patients at risk for the adult respiratory-distress syndrome. N Engl J Med. 1984 Aug 2;311(5):281–286. doi: 10.1056/NEJM198408023110502. [DOI] [PubMed] [Google Scholar]
  26. Pepe P. E., Potkin R. T., Reus D. H., Hudson L. D., Carrico C. J. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982 Jul;144(1):124–130. doi: 10.1016/0002-9610(82)90612-2. [DOI] [PubMed] [Google Scholar]
  27. Peters J. I., Bell R. C., Prihoda T. J., Harris G., Andrews C., Johanson W. G. Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome. Am Rev Respir Dis. 1989 May;139(5):1163–1168. doi: 10.1164/ajrccm/139.5.1163. [DOI] [PubMed] [Google Scholar]
  28. Petty T. L. Indicators of risk, course, and prognosis in adult respiratory distress syndrome (ARDS) Am Rev Respir Dis. 1985 Sep;132(3):471–471. doi: 10.1164/arrd.1985.132.3.471. [DOI] [PubMed] [Google Scholar]
  29. Rinaldo J. E. Indicators of risk, course, and prognosis in adult respiratory distress syndrome. Am Rev Respir Dis. 1986 Feb;133(2):343–344. doi: 10.1164/arrd.1986.133.2.343. [DOI] [PubMed] [Google Scholar]
  30. Rinaldo J. E., Rogers R. M. Adult respiratory distress syndrome. N Engl J Med. 1986 Aug 28;315(9):578–580. doi: 10.1056/NEJM198608283150909. [DOI] [PubMed] [Google Scholar]
  31. Robbins R. A., Russ W. D., Rasmussen J. K., Clayton M. M. Activation of the complement system in the adult respiratory distress syndrome. Am Rev Respir Dis. 1987 Mar;135(3):651–658. doi: 10.1164/arrd.1987.135.3.651. [DOI] [PubMed] [Google Scholar]
  32. Rose D. M., Downs J. B., Heenan T. J. Temporal responses of functional residual capacity and oxygen tension to changes in positive end-expiratory pressure. Crit Care Med. 1981 Feb;9(2):79–82. doi: 10.1097/00003246-198102000-00001. [DOI] [PubMed] [Google Scholar]
  33. Rouby J. J., Fusciardi J., Bourgain J. L., Viars P. High-frequency jet ventilation in postoperative respiratory failure: determinants of oxygenation. Anesthesiology. 1983 Oct;59(4):281–287. doi: 10.1097/00000542-198310000-00003. [DOI] [PubMed] [Google Scholar]
  34. Schonfeld S. A., Ploysongsang Y., DiLisio R., Crissman J. D., Miller E., Hammerschmidt D. E., Jacob H. S. Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med. 1983 Oct;99(4):438–443. doi: 10.7326/0003-4819-99-4-438. [DOI] [PubMed] [Google Scholar]
  35. Seidenfeld J. J., Pohl D. F., Bell R. C., Harris G. D., Johanson W. G., Jr Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1986 Jul;134(1):12–16. doi: 10.1164/arrd.1986.134.1.12. [DOI] [PubMed] [Google Scholar]
  36. Shoemaker W. C., Appel P. L. Effects of prostaglandin E1 in adult respiratory distress syndrome. Surgery. 1986 Mar;99(3):275–283. [PubMed] [Google Scholar]
  37. Shoemaker W. C., Appel P. L., Kram H. B., Waxman K., Lee T. S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest. 1988 Dec;94(6):1176–1186. doi: 10.1378/chest.94.6.1176. [DOI] [PubMed] [Google Scholar]
  38. Snapper J. R., Hutchison A. A., Ogletree M. L., Brigham K. L. Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J Clin Invest. 1983 Jul;72(1):63–76. doi: 10.1172/JCI110985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Suter P. M., Fairley B., Isenberg M. D. Optimum end-expiratory airway pressure in patients with acute pulmonary failure. N Engl J Med. 1975 Feb 6;292(6):284–289. doi: 10.1056/NEJM197502062920604. [DOI] [PubMed] [Google Scholar]
  40. Tate R. M., Repine J. E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. doi: 10.1164/arrd.1983.128.3.552. [DOI] [PubMed] [Google Scholar]
  41. Tharratt R. S., Allen R. P., Albertson T. E. Pressure controlled inverse ratio ventilation in severe adult respiratory failure. Chest. 1988 Oct;94(4):755–762. doi: 10.1378/chest.94.4.755. [DOI] [PubMed] [Google Scholar]
  42. Tracey K. J., Lowry S. F., Fahey T. J., 3rd, Albert J. D., Fong Y., Hesse D., Beutler B., Manogue K. R., Calvano S., Wei H. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet. 1987 May;164(5):415–422. [PubMed] [Google Scholar]
  43. Villar J., Slutsky A. S. The incidence of the adult respiratory distress syndrome. Am Rev Respir Dis. 1989 Sep;140(3):814–816. doi: 10.1164/ajrccm/140.3.814. [DOI] [PubMed] [Google Scholar]
  44. Webster N. R., Cohen A. T., Nunn J. F. Adult respiratory distress syndrome--how many cases in the UK? Anaesthesia. 1988 Nov;43(11):923–926. doi: 10.1111/j.1365-2044.1988.tb05652.x. [DOI] [PubMed] [Google Scholar]
  45. Weigelt J. A. Current concepts in the management of the adult respiratory distress syndrome. World J Surg. 1987 Apr;11(2):161–166. doi: 10.1007/BF01656398. [DOI] [PubMed] [Google Scholar]
  46. Weigelt J. A., Norcross J. F., Borman K. R., Snyder W. H., 3rd Early steroid therapy for respiratory failure. Arch Surg. 1985 May;120(5):536–540. doi: 10.1001/archsurg.1985.01390290018003. [DOI] [PubMed] [Google Scholar]
  47. Weinberg P. F., Matthay M. A., Webster R. O., Roskos K. V., Goldstein I. M., Murray J. F. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis. 1984 Nov;130(5):791–796. doi: 10.1164/arrd.1984.130.5.791. [DOI] [PubMed] [Google Scholar]
  48. Wiener-Kronish J. P., Gropper M. A., Matthay M. A. The adult respiratory distress syndrome: definition and prognosis, pathogenesis and treatment. Br J Anaesth. 1990 Jul;65(1):107–129. doi: 10.1093/bja/65.1.107. [DOI] [PubMed] [Google Scholar]
  49. Zapol W. M., Snider M. T., Hill J. D., Fallat R. J., Bartlett R. H., Edmunds L. H., Morris A. H., Peirce E. C., 2nd, Thomas A. N., Proctor H. J. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979 Nov 16;242(20):2193–2196. doi: 10.1001/jama.242.20.2193. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES